IMAX Co. (NYSE:IMAX – Get Free Report) CFO Natasha Fernandes sold 2,957 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $25.52, for a total value of $75,462.64. Following the sale, the chief financial officer now directly owns 14,883 shares of the company’s stock, valued at approximately $379,814.16. This trade represents a 16.58 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
IMAX Stock Performance
Shares of NYSE IMAX opened at $25.84 on Wednesday. IMAX Co. has a 1 year low of $13.20 and a 1 year high of $26.84. The stock’s 50-day simple moving average is $23.16 and its 200-day simple moving average is $20.28. The firm has a market cap of $1.36 billion, a price-to-earnings ratio of 58.73, a PEG ratio of 1.68 and a beta of 1.23.
IMAX (NYSE:IMAX – Get Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.12. IMAX had a return on equity of 7.53% and a net margin of 6.74%. The company had revenue of $91.50 million for the quarter, compared to analyst estimates of $93.71 million. During the same period in the prior year, the company posted $0.27 EPS. IMAX’s quarterly revenue was down 11.9% on a year-over-year basis. As a group, research analysts predict that IMAX Co. will post 0.77 EPS for the current year.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on the company. Barrington Research reiterated an “outperform” rating and set a $24.00 target price on shares of IMAX in a report on Thursday, October 31st. StockNews.com downgraded shares of IMAX from a “buy” rating to a “hold” rating in a research note on Tuesday. Rosenblatt Securities reissued a “buy” rating and issued a $28.00 target price on shares of IMAX in a research note on Thursday, October 31st. Roth Mkm upped their price target on shares of IMAX from $27.00 to $28.00 and gave the stock a “buy” rating in a research report on Thursday, October 31st. Finally, Wedbush reissued an “outperform” rating on shares of IMAX in a research report on Wednesday, November 27th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, IMAX presently has a consensus rating of “Moderate Buy” and a consensus target price of $24.22.
Read Our Latest Research Report on IMAX
IMAX Company Profile
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
Further Reading
- Five stocks we like better than IMAX
- Stock Dividend Cuts Happen Are You Ready?
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.